• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用兵库评分进行复发风险分层和选择结直肠癌肝转移的围手术期化疗。

Recurrence-risk stratification using the Beppu score and selection of perioperative chemotherapy for colorectal liver metastases.

机构信息

Department of Surgery, Yamaga City Medical Center, Yamaga, Japan.

Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan.

出版信息

J Surg Oncol. 2024 Apr;129(5):893-900. doi: 10.1002/jso.27590. Epub 2024 Jan 18.

DOI:10.1002/jso.27590
PMID:38239092
Abstract

The annual postoperative disease-free survival for colorectal liver metastases can be easily estimated by weighting six preoperative clinical parameters (Beppu score). We identified three recurrence-risk stratification groups: the low (≤6 points), moderate (7-10 points), and high-risk (≥11 points). For low-, moderate-, and high-risk patients, hepatectomy alone, hepatectomy with adjuvant chemotherapy, and hepatectomy with preoperative chemotherapy are recommended, respectively. The Beppu score enables the decision on the necessity and timing of perioperative chemotherapy.

摘要

结直肠肝转移术后无病生存率可通过对术前 6 项临床参数(贝普评分)进行加权计算来进行简单预测。我们确定了三个复发风险分层组:低危(≤6 分)、中危(7-10 分)和高危(≥11 分)。对于低危、中危和高危患者,分别推荐单独肝切除术、肝切除术联合辅助化疗和肝切除术联合术前化疗。贝普评分有助于决定围手术期化疗的必要性和时机。

相似文献

1
Recurrence-risk stratification using the Beppu score and selection of perioperative chemotherapy for colorectal liver metastases.使用兵库评分进行复发风险分层和选择结直肠癌肝转移的围手术期化疗。
J Surg Oncol. 2024 Apr;129(5):893-900. doi: 10.1002/jso.27590. Epub 2024 Jan 18.
2
High-risk Patients With Colorectal Liver Metastases Assessed by the Beppu Score Can Have Excellent Survival Through Multidisciplinary Treatment Including Local Ablation.贝普评分评估的结直肠癌肝转移高危患者可通过包括局部消融在内的多学科治疗获得极好的生存。
Anticancer Res. 2024 Apr;44(4):1533-1539. doi: 10.21873/anticanres.16950.
3
Validation study of the JSHBPS nomogram for patients with colorectal liver metastases who underwent hepatic resection in the recent era - a nationwide survey in Japan.在近期时代接受肝切除术的结直肠癌肝转移患者的 JSHBPS 列线图验证研究-日本的全国性调查。
J Hepatobiliary Pancreat Sci. 2023 May;30(5):591-601. doi: 10.1002/jhbp.1256. Epub 2022 Nov 8.
4
Indication for neoadjuvant chemotherapy in patients with colorectal liver metastases based on a nomogram that predicts disease-free survival.基于预测无病生存期的列线图确定结直肠癌肝转移患者新辅助化疗的适应症。
J Hepatobiliary Pancreat Sci. 2014 Dec;21(12):881-8. doi: 10.1002/jhbp.149. Epub 2014 Aug 25.
5
A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.预测接受肝切除术治疗结直肠肝转移患者无病生存的列线图:日本肝胆胰外科学会肝脏外科研讨会项目的多中心数据收集。
J Hepatobiliary Pancreat Sci. 2012 Jan;19(1):72-84. doi: 10.1007/s00534-011-0460-z.
6
Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.结直肠肝转移术后高危肝复发患者的辅助化疗:奥沙利铂肝动脉灌注与现代全身化疗的对比研究。
Ann Surg. 2013 Jan;257(1):114-20. doi: 10.1097/SLA.0b013e31827b9005.
7
Role of adjuvant therapy after resection of colorectal cancer liver metastases.结直肠癌肝转移术后辅助治疗的作用。
J Clin Oncol. 2010 May 1;28(13):2300-9. doi: 10.1200/JCO.2009.26.9340. Epub 2010 Apr 5.
8
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases.结直肠肝肺转移瘤潜在治愈性切除术后辅助全身化疗。
Clin Colorectal Cancer. 2013 Sep;12(3):188-94. doi: 10.1016/j.clcc.2013.04.002. Epub 2013 Jun 14.
9
Resectable colorectal liver metastases: optimal sequencing of chemotherapy.可切除的结直肠癌肝转移:化疗的最佳顺序
J Gastrointest Cancer. 2012 Sep;43(3):496-8. doi: 10.1007/s12029-011-9272-2.
10
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.围手术期 FOLFOX4 化疗联合手术与单纯手术治疗结直肠癌可切除肝转移(EORTC 40983):一项随机、对照、3 期临床试验的长期结果。
Lancet Oncol. 2013 Nov;14(12):1208-15. doi: 10.1016/S1470-2045(13)70447-9. Epub 2013 Oct 11.

引用本文的文献

1
Simple definition of biologically borderline resectable colorectal liver metastases based on early surgical failure.基于早期手术失败对生物学上临界可切除的结直肠癌肝转移进行简单定义。
Int J Clin Oncol. 2025 Mar 30. doi: 10.1007/s10147-025-02752-y.
2
-Beppu Classification: A New Recurrence Risk Classification System Incorporating the Beppu Score and Status for Colorectal Liver Metastases.别府分类:一种结合别府评分和结直肠癌肝转移状态的新复发风险分类系统。
Cancers (Basel). 2025 Feb 14;17(4):640. doi: 10.3390/cancers17040640.
3
How Can We Improve the Survival of Patients with Colorectal Liver Metastases Using Thermal Ablation?
我们如何通过热消融提高结直肠癌肝转移患者的生存率?
Cancers (Basel). 2025 Jan 9;17(2):199. doi: 10.3390/cancers17020199.
4
Comprehensive data of 5085 patients newly diagnosed with colorectal liver metastasis between 2013 and 2017: Fourth report of a nationwide survey in Japan.2013年至2017年间新诊断为结直肠癌肝转移的5085例患者的综合数据:日本全国性调查的第四次报告。
J Hepatobiliary Pancreat Sci. 2025 Jan;32(1):26-43. doi: 10.1002/jhbp.12078. Epub 2024 Nov 12.